Anne MacGregor

National Migraine and Headache Awareness Month Spotlights New Advances and Greater Understanding

Retrieved on: 
Tuesday, June 1, 2021
Human resources, University, Pharmaceutical, Training, Education, Managed care, Professional services, Mental health, Philanthropy, Fitness & Nutrition, Fund Raising, Foundation, Science, Nursing, Research, Health, Headaches, Migraine, Medicine, Branches of biology, Headache, Clinical medicine, International Classification of Headache Disorders, Anne MacGregor

The National Headache Foundation today released the following statement about National Migraine and Headache Awareness Month from Thomas Dabertin, MBA, executive director and chief executive officer of the National Headache Foundation:

Key Points: 
  • The National Headache Foundation today released the following statement about National Migraine and Headache Awareness Month from Thomas Dabertin, MBA, executive director and chief executive officer of the National Headache Foundation:
    More than 40 million people in the United States are living with migraine disease and headache disorders.
  • I had my first migraine in my teens, and it was one of the reasons that motivated me to lead the National Headache Foundation.
  • June is National Migraine and Headache Awareness Month; our time on the national stage, and I hope you will join me in finding a way to help yourself, a loved one, friend or co-worker better understand migraine disease and headache disorders.
  • The NHFs Annual Gala has raised millions of dollars to go towards migraine and headache research, education, awareness and advocacy.

Association of Migraine Disorders Launches $100,000 Matching Challenge For "Research Is Hope" Campaign

Retrieved on: 
Monday, November 9, 2020
Migraine, Medicine, Clinical medicine, Branches of biology, Anne MacGregor

PROVIDENCE, R.I., Nov. 9, 2020 /PRNewswire/ -- The Association of Migraine Disorders (AMD) launched its "Research is Hope" campaign to raise money for innovative research that aims to improve patient care.

Key Points: 
  • PROVIDENCE, R.I., Nov. 9, 2020 /PRNewswire/ -- The Association of Migraine Disorders (AMD) launched its "Research is Hope" campaign to raise money for innovative research that aims to improve patient care.
  • The campaign shares five stories of people whose lives have been drastically changed by migraine.
  • Becky Dwyer lost her daughter, Melissa, to suicide due to chronic migraine.
  • The Association of Migraine Disorders is a non-profit with a mission to expand the understanding of migraine through research, education and awareness.AMD is led by a wide range of healthcare professionals that understand the spectrum of symptoms associated with migraine.

Europe Migraine Market and Competitive Landscape Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 18, 2020
General Health, Pharmaceutical, Health, Migraine, Migraine treatment, Market share, Anne MacGregor

The "Europe Migraine Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Migraine Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • Europe Migraine Market and Competitive Landscape - 2020, provides comprehensive insights into the Migraine pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts the Migraine market size and drug sales.
  • This research covers the following:
    Migraine treatment options, Migraine late stage clinical trials pipeline, Migraine prevalence by countries, Migraine market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine

Retrieved on: 
Friday, July 12, 2019
Migraine, Medicine, Health, Anne MacGregor, Migraine treatment

"These results revealed that more efforts are needed to help people with migraine access appropriate primary and specialist care."

Key Points: 
  • "These results revealed that more efforts are needed to help people with migraine access appropriate primary and specialist care."
  • With the knowledge gained from the OVERCOME study, we should be better positioned to understand the issues and advance recommendations to close this and other gaps in the treatment of migraine."
  • The Observational Survey of the Epidemiology, Treatment and Care of Migraine(OVERCOME) study aims to further understand the burden of migraine and stigma experienced by people living with the disease, identify barriers to appropriate treatment of migraine and assess how the introduction of novel treatment options may influence delivery of migraine care and outcomes.
  • P-LLY
    Buse D. et al, Migraine Care Across the Healthcare Landscape in the United States Among Those with 4 Migraine Headache Days per Month: Results of the OVERCOME study.

Global Leaders in Migraine Research to Convene at The American Headache Society 61st Annual Scientific Meeting

Retrieved on: 
Tuesday, June 25, 2019
Headaches, Medicine, Headache, Neurology, Migraine, Health, Anne MacGregor

Join the conversation at: https://www.facebook.com/ahsheadache/

Key Points: 
  • Join the conversation at: https://www.facebook.com/ahsheadache/
    "The American Headache Society is honored to provide this forum for researchers and clinicians at the forefront of a tremendous sea change in the understanding and treatment of migraine and other headache disorders," said American Headache Society CEO Howard Rosen.
  • The diverse scientific and clinical data to be presented at the AHS Annual Scientific Meeting will bring us closer to the common goal of reducing this burden.
  • The American Headache Society (AHS) is a professional society of healthcare providers dedicated to the study and treatment of headache and face pain.
  • AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, and publication of the journal Headache.

The American Headache Society's 60th Annual Scientific Meeting to Spotlight Cutting-Edge Science, Novel Therapeutic Options and the Potential for Improvement in the Lives of Individuals with Migraine

Retrieved on: 
Wednesday, June 6, 2018
Headaches, Medicine, Clinical medicine, Migraine, Neurology, Anne MacGregor

"This is an unrivaled era for headache disorders, providing patients with much needed hope and concrete advances."

Key Points: 
  • "This is an unrivaled era for headache disorders, providing patients with much needed hope and concrete advances."
  • The data to be highlighted at the AHS Annual Scientific Meeting brings new understanding of the epidemiology, as well as prevention and treatment of migraine.
  • The American Headache Society (AHS) is a professional society of healthcare providers dedicated to the study and treatment of headache and face pain.
  • AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, and publication of the journal Headache.

New Study Reveals Non-Prescription Migraine Treatment Safe and Effective

Retrieved on: 
Monday, May 7, 2018
Migraine, Clinical medicine, Medicine, Pain, Paracetamol, Headache, Cephalalgia, Almotriptan, Anne MacGregor

Cephalalgia Reports , a neurological journal in association with the International Headache Society, has concluded the supplement to be safe after a comprehensive review published on May 2, 2018.

Key Points: 
  • Cephalalgia Reports , a neurological journal in association with the International Headache Society, has concluded the supplement to be safe after a comprehensive review published on May 2, 2018.
  • Petadolex, a non-prescription supplement taken to prevent migraine attacks, has come under scrutiny due to concerns it might cause liver damage.
  • The study is authored by neurologists and headache researchers Hans Diener, M.D.
  • According to Dr. Freitag, "This study confirms the safety of Petadolex concerning hepatic toxicity and reinforces its role as a top tier agent based upon efficacy and safety for migraine prevention."